U.S. Hospitality Stock News

If you are wondering whether Indivior at around US$35.89 still offers value after a strong run, this article will walk through what the current price might be implying about the company. The stock has delivered a 196.9% return over the last year and a 414.6% return over five years, although the last 30 days saw a 1.9% decline and the last week was flat. Investors have been reacting to ongoing news flow around the company and its position in the pharmaceutical and biotech space, which...

Rayonier stock: recent performance snapshot Rayonier (RYN) has attracted fresh attention after recent trading left the shares at US$21.66, with returns near flat over the past week and a negative move over the past 3 months and year. See our latest analysis for Rayonier. At the current share price of US$21.66, Rayonier’s recent drift lower, including a 17.45% 3 month share price decline and a 6.67% 1 year total shareholder return decline, points to fading momentum as investors reassess its...

If you are wondering whether Leonardo DRS is still reasonably priced after its recent run, this article walks through what the current numbers may imply about value. The stock most recently closed at US$37.20, with returns of 9.1% over 7 days, 9.7% over 30 days, 7.0% year to date and 12.9% over the past year, as well as a very large 3 year return of 194.0%. Recent coverage has focused on Leonardo DRS as a US defense and electronics business, with investors watching how its positioning in...

PriceSmart, Inc. has released its fiscal first-quarter 2026 results, reporting net income of US$40.2 million, earnings of US$1.29 per share, and revenue of US$1.38 billion from its 56 warehouse clubs across 12 countries and one U.S. territory. The company also highlighted 8.0% comparable net merchandise sales growth and outlined plans to expand to 60 clubs, including a tenth location in Costa Rica, underscoring continued emphasis on club rollouts in existing markets. Next, we’ll examine how...

If you are wondering whether Tandem Diabetes Care's share price still reflects its true worth, you are not alone. The stock has drawn attention from investors who are trying to work out if the current level makes sense. The shares last closed at US$23.54, with recent returns of 4.6% over 7 days, 12.5% over 30 days and 9.2% year to date, set against a 36.5% decline over 1 year, a 47.0% decline over 3 years, and a 74.7% decline over 5 years. Recent attention on Tandem Diabetes Care has been...

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...

Wondering if Choice Hotels International is priced attractively right now, or if the current share price is already baking in most of the upside? The stock last closed at US$104.68, with returns of 8.7% over 7 days and 22.1% over 30 days, while the 1 year return is a 24.6% decline and the 3 year and 5 year returns are 5.5% and 1.5% respectively. Recent attention on Choice Hotels International has centered on how the business is positioned within the wider consumer services sector and how...

If you are wondering whether Byrna Technologies at around US$17.50 is a bargain or already pricing in a lot of optimism, you are in the right place. The stock has been through a mixed patch, with a 1.4% gain over the last week, an 11.0% decline over the past month, a 4.7% gain year to date, a 35.3% decline over the past year, and a 94.4% gain over three years that leaves the five year return at 25.0%. These swings have kept Byrna Technologies on the radar of investors watching how sentiment...

Today we're going to take a look at the well-established Warner Music Group Corp. ( NASDAQ:WMG ). The company's stock...

Insiders who bought US$3.82m worth of Mercer International Inc. ( NASDAQ:MERC ) stock in the last year have seen some...

Anyone interested in Rapport Therapeutics, Inc. ( NASDAQ:RAPP ) should probably be aware that the Founder & Chief...

If you are wondering whether Ellington Financial at around US$13.53 is offering good value today, you are not alone. This article is designed to walk you through that question step by step. The stock has had a mixed short term run, with returns of a 1.6% decline over 7 days, a 1.4% decline over 30 days and a 1.1% decline year to date. The longer term picture shows 24.4% over 1 year, 51.1% over 3 years and 62.1% over 5 years. Recent attention on Ellington Financial has centered around its...

If you are wondering whether Vericel's current share price lines up with its underlying worth, this article walks through the numbers in a clear, structured way. Vericel recently closed at US$39.34, with returns of 9.2% over 7 days, 5.5% over 30 days, 10.5% year to date, a 33.9% decline over 1 year, 42.4% over 3 years and 6.6% over 5 years. Taken together, these figures provide a mix of shorter term momentum and longer term context. That performance sits against a backdrop of ongoing...

As the U.S. stock market experiences mixed movements with the Dow Jones and S&P 500 reaching fresh all-time highs, investors are keeping a close eye on geopolitical developments and economic indicators such as employment data. In this environment, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best and may offer resilience amid market fluctuations.

Major stock indexes in the United States have recently shown mixed performance, with the Dow Jones Industrial Average and S&P 500 setting fresh all-time highs. Amid these fluctuating market conditions, investors are increasingly exploring diverse opportunities to maximize potential returns. Penny stocks, though a term from earlier market days, continue to represent intriguing investment prospects by offering access to smaller or newer companies at lower price points. By identifying those with...

As the Dow Jones and S&P 500 reach new all-time highs, the U.S. stock market continues to capture investors' attention amidst mixed economic signals, including a weakening labor market and geopolitical developments. In this dynamic environment, identifying promising small-cap stocks can offer valuable opportunities for growth, particularly when these companies demonstrate resilience and potential in sectors poised for expansion.

Delcath Systems (DCTH) is back in focus after publishing detailed subgroup analyses from its phase 3 FOCUS study on HEPZATO KIT in unresectable metastatic uveal melanoma, helping refine how clinicians view efficacy and safety across different patient groups. See our latest analysis for Delcath Systems. The publication arrives after a mixed stretch for Delcath Systems, with a 30 day share price return of 6.85% and a 90 day share price return decline of 5.86%. The 3 year total shareholder...

TETRA Technologies recently announced that its senior management participated in the 28th Annual Needham Growth Conference and the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference, hosting investor meetings and webcasts to outline its energy services, lithium, and low‑carbon technology initiatives. This heightened investor outreach, combined with growing attention on TETRA’s lithium and energy transition projects, has pushed the company into focus for higher‑risk,...

Investors can buy low cost index fund if they want to receive the average market return. But if you invest in...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more...

If you are asking whether Tempus AI is priced attractively or already baking in a lot of optimism, the rest of this article is built to help you assess that question clearly. Tempus AI shares last closed at US$69.54, with returns of 15.2% over the past 7 days, an 11.5% gain year to date and a 78.9% return over the last year. The 30 day return sits at a 9.3% decline. Recent attention on Tempus AI has centered on its position in applying AI tools to healthcare data and its potential role in...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Yum China Holdings' (NYSE:YUMC) stock is up by a considerable 12% over the past three months. We wonder if and what...